| Tag | Content |
|---|
EnhancerAtlas ID | HS184-13547 |
Organism | Homo sapiens |
Tissue/cell | T47D |
Coordinate | chr17:40446250-40446960 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr17:40446727-40446748 | GAACAGAAACAGAAAGCACAC | - | 6.49 | | REST | MA0138.2 | chr17:40446360-40446381 | ATCCATGTCCATGGTGCTGGT | - | 6.1 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_00124 | chr17:40445059-40448531 | Adipose_Nuclei | | SE_13352 | chr17:40446142-40447952 | CD34_Primary_RO01536 | | SE_18328 | chr17:40444609-40448657 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19202 | chr17:40445402-40447030 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_39848 | chr17:40446140-40448124 | K562 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I042292 | chr17 | 40444610 | 40448657 |
|
Enhancer Sequence | GGTTAGAAAC CAGGTCACAA AGGGTCTTCC AGCACAGCCC CTGTGTCCCT GACTTGTTGC 60
CATCACAGAG CTATCTGCAA ACCTAAAAAT GACTTCAGCC TCATTGACAA ATCCATGTCC 120
ATGGTGCTGG TGCTGTCATG GTCTGGGAGC TCATTCCTTC CTCCAACCAT ACAACTGTTC 180
CTGAACACCC CTGGCATTCT AGGGCTTGGG GATTCTGTAG TTCACAGGAA AGGCAAGGTC 240
CTAGCCCTTG GGAACCTCAC ATCCTTGTGC AGGGAGACAG ACAGAAACAT GTAAGCAAAT 300
ACAAGAACAA CACACTTTTA GATAGGACTA CTGTGAATTG GCTCGTCAGA GATGACCCCT 360
CTGCAATGGT ACCAGTTAAA GTGCTTTGCC TCAGGAGGAT CTGATGCCAG AATGTTCCAG 420
ACTGTTGGAA CAATAAGTGC AAGGGCCCCA GGGCAGGAAC ATGCCTGTGT GTTCAAGGAA 480
CAGAAACAGA AAGCACACAT TCCCAGCGAG CTGGGGTTGG AGGTAGGCAG GGCTATGGCC 540
AGCAGACACC ATGGGAAGGG GTTTGGATTT TATTCTGAGA ACAGTTCATT GGAAAGCCTC 600
TGAGGACTTG TTCCTCTTCA TCCATGTGCT CCCTCCCTTT GTGACCTGGT TTCTACCCCT 660
CTCTCTCTAT TTTTTTTTTT TTTGAAACGG AGTCTCGCTG TGTTGCCAAG 710
|
